Results 91 to 100 of about 362,795 (239)

pneumonia in a healthy immunocompetent patient: A case report and literature review

open access: yesSAGE Open Medical Case Reports
Pneumocystis jirovecii pneumonia, typically an opportunistic infection, is commonly associated with risk factors such as low CD4+ lymphocyte count, underlying malignancies, organ transplantation, or immunosuppressive medications.
Houda Rouis   +6 more
doaj   +1 more source

Serum markers in interstitial pneumonia with and without Pneumocystis jirovecii colonization: a prospective study

open access: yesBMC Infectious Diseases, 2009
Background In patients with chronic respiratory disease, Pneumocystis jirovecii (P. jirovecii) colonization is observed, and may influence disease progression and systemic inflammation.
Shimizu Yasuo   +6 more
doaj   +1 more source

Twice Weekly Sulfamethoxazole/Trimethoprim for Pneumocystis jiroveci Pneumonia Prophylaxis in Lung Transplant Recipients

open access: yesTransplant Infectious Disease, EarlyView.
A novel regimen of sulfamethoxazole/trimethoprim single strength one tablet twice weekly for Pneumocystis jiroveci Pneumonia (PJP) prophylaxis in lung transplant patients found no cases of PJP over an 8‐year period and may reduce the incidence of medication discontinuation due to adverse effects. ABSTRACT Background Pneumocystis jiroveci pneumonia (PJP)
Chloe Munroe   +8 more
wiley   +1 more source

Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients.

open access: yesJournal of Antimicrobial Chemotherapy, 2016
Pneumocystis jirovecii can cause life-threatening pneumonia following treatment for haematological malignancies or after HSCT. The mortality rate of P. jirovecii pneumonia (PCP) in these patients is 30%-60%, especially after HSCT.
C. Cordonnier   +12 more
semanticscholar   +1 more source

High prevalence of Pneumocystis jirovecii pneumonia among Mozambican children < 5 years of age admitted to hospital with clinical severe pneumonia [PDF]

open access: yes, 2016
We aimed to describe Pneumocystis jirovecii pneumonia (PCP) prevalence and features in children from sub-Saharan Africa, and to investigate PCP-associated risk factors.
Acácio, Sozinho   +12 more
core   +1 more source

A case of Talaromyces marneffei infection that required differentiation from Pneumocystis pneumonia

open access: yesIDCases, 2023
We report a case of Talaromyces marneffei fungemia in a patient with HIV infection with a history of travelling to southern China. At first, Pneumocystis pneumonia was considered in this case because chest CT images showed typical ground-glass opacity ...
Mieko Tokano   +8 more
doaj  

Infectious Morbidity During Pediatric Acute Myeloid Leukemia Chemotherapy in a High‐Income Country: A 15‐Year Population‐Based Overview

open access: yesPediatric Blood &Cancer, Volume 72, Issue 8, August 2025.
ABSTRACT Introduction Infection causes significant morbidity and mortality in pediatric acute myeloid leukemia (pAML). This study describes the incidence and risk factors of bloodstream infection (BSI) and invasive fungal infection (IFI) in pAML. Methods A retrospective chart review was performed of patients treated according to the ANLL‐97/AML‐12 (N =
Emily R. Schwartz   +13 more
wiley   +1 more source

Recent Advances in the Diagnosis of Pneumocystis Pneumonia.

open access: yesMedical Mycology Journal, 2016
Pneumocystis jirovecii is a prototypical opportunistic pathogen, causing an asymptomatic or mild infection in normal hosts and fulminating pneumonia (Pneumocystis pneumonia, PCP) in immunocompromised hosts.
Yinggai Song   +3 more
semanticscholar   +1 more source

Coinfection of Invasive Pulmonary Aspergillosis and Pneumocystis Jiroveci Pneumonia in a Non-HIV Patient [PDF]

open access: yes, 2007
Invasive pulmonary aspergillosis (IPA) and pneumocystis jiroveci pneumonia (PCP) are life-threatening opportunistic infections that occur in immunocompromised hosts.
Hisada, Takeshi   +8 more
core   +1 more source

Invasive Fungal Infections in Orthotopic Heart Transplant Patients: Incidence and Risk Factors in the Modern Era

open access: yesClinical Transplantation, Volume 39, Issue 8, August 2025.
ABSTRACT Background Invasive fungal infections (IFI) post‐orthotopic heart transplant (OHT) have not been well studied due to limited information in large databases. The goal of the study is to describe the incidence and risk factors for IFI. Methods In this retrospective cohort study, we analyzed risk factors associated with IFI among OHT recipients ...
Lana Hasan   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy